# Eloxx Pharmaceuticals, Inc.: Form 8-K, filed Oct 22, 2026

- Company: [Eloxx Pharmaceuticals, Inc.](/companies/elox.md) (CIK 1035354)
- Form: 8-K
- Filed: 2026-10-22
- Accepted by EDGAR: Oct 21, 2026, 19:31 ET
- Period: 2026-10-19
- Accession: 0001193125-26-428116
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1035354/000119312526428116/d462611d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1035354/000119312526428116/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1035354/000119312526428116/d462611d8k.htm

Filed Oct 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-428116. Last ingested by Listed: Nov 15, 2026, 04:18 ET. No prices; not investment advice.
